India's Akum Drugs rises on agreement with South Korean co

Caregen

19/11/2024 07:25

** Akum Drugs and Pharmaceuticals  AKUM.NS  rises to
exchange-allowed upper circuit of 5% to 580.7 rupees
    ** Co enters into agreement with Caregen  214370.KQ , a
South Korean firm that makes cosmeceuticals and dermal fillers
    ** Deal grants Akum exclusive rights to sell certain Caregen
products in India
    ** Stock set to snap 10 sessions of losses
    ** About 2.3 mln shares traded, 10.4x 30-day avg
    ** AKUM down 23.7% since listing on Aug. 6, as of last close

 (Reporting by Anuran Sadhu in Bengaluru)
 ((Anuran.Sadhu@thomsonreuters.com; +91 8697274436;))